Pseudomonas aeruginosa is an important etiological agent of diabetic foot ulcers. It is included in the World Health Organization’s priority list of organisms for which new antibiotics or alternatives are urgently needed. The rise in antimicrobial resistance highlights the urgent need to explore alternatives to antimicrobial drugs.
Methods:
In this study, we isolated the bacteriophage Ps1.JH from hospital sewage water targeting a locally isolated strain of Pseudomonas aeruginosa.
Results:
Ps1.JH can inhibit bacterial growth for up to 24 h. It is stable at pH 4–9 and temperature up to 60°C. Ps1.JH has double stranded DNA genome of 72.67 kb with 55% GC content, encoding 91 open reading frames. According to ICTV classification, Ps1.JH belongs to the genus Litunavirus of Schitoviridae family. It does not encode any integrase, repressor, virulence factor, or toxin.
Conclusion:
Ps1.JH could be a potential candidate for controlling P. aeruginosa of diabetic foot ulcer origin after further analyses.
MohammedB, AbdullahA, RayshanA. Molecular identification of several Pseudomonas aeruginosa virulence genes. J Anim Health Prod, 2024; 12(s1):67–74.
2.
AlhazmiA. Pseudomonas aeruginosa-pathogenesis and pathogenic mechanisms. Ijb, 2015; 7(2):44.
3.
CroneS, Vives‐FlórezM, KvichL, et al.The environmental occurrence of Pseudomonas aeruginosa. Apmis, 2020; 128(3):220–231.
4.
MittalR, AggarwalS, SharmaS, et al.Urinary tract infections caused by Pseudomonas aeruginosa: A minireview. J Infect Public Health, 2009; 2(3):101–111.
5.
KollefMH, TorresA, ShorrAF, et al.Nosocomial infection. Crit Care Med, 2021; 49(2):169–187.
6.
MendesJJ, LeandroC, Corte‐RealS, et al.Wound healing potential of topical bacteriophage therapy on diabetic cutaneous wounds. Wound Repair Regen, 2013; 21(4):595–603.
7.
SaleemM, KhanMS, NeyazA, et al.Multidrug resistance, biofilm formation, and genetic determinants in diabetic foot infections from Uttar Pradesh, India: A clinical-microbiological insight from a prospective study. Naunyn Schmiedebergs Arch Pharmacol, 2025; 398(11):15965–15981.
8.
AdenijiOO, NontonganaN, OkohJC, et al.The potential of antibiotics and nanomaterial combinations as therapeutic strategies in the management of multidrug-resistant infections: A review. Int J Mol Sci, 2022; 23(23):15038.
9.
HsuY-M. Regulation of Actinobacillus pleuropneumoniae ApxI expression. Cornell University: 2001.
10.
UdaondoZ, MolinaL, SeguraA, et al.Analysis of the core genome and pangenome of P seudomonas putida. Environ Microbiol, 2016; 18(10):3268–3283.
11.
AvakhA, GrantGD, CheesmanMJ, et al.The art of war with Pseudomonas aeruginosa: Targeting Mex efflux pumps directly to strategically enhance antipseudomonal drug efficacy. Antibiotics (Basel), 2023; 12(8):1304.
12.
KothariA, KherdekarR, MagoV, et al.Age of antibiotic resistance in MDR/XDR clinical pathogen of Pseudomonas aeruginosa. Pharmaceuticals (Basel), 2023; 16(9):1230.
13.
CulotA, GrossetN, GautierM. Overcoming the challenges of phage therapy for industrial aquaculture: A review. Aquaculture, 2019; 513:734423.
14.
SinghJ, YeohE, FitzgeraldDA, et al.A systematic review on the use of bacteriophage in treating Staphylococcus aureus and Pseudomonas aeruginosa infections in cystic fibrosis. Paediatr Respir Rev, 2023; 48:3–9.
15.
AlviIA, AsifM, TabassumR, et al.RLP, a bacteriophage of the family Podoviridae, rescues mice from bacteremia caused by multi-drug-resistant Pseudomonas aeruginosa. Arch Virol, 2020; 165(6):1289–1297.
16.
KutterE. Phage host range and efficiency of plating. Bacteriophages: Methods and protocols, Volume 1: Isolation, characterization, and interactions. Methods Mol Biol, 2009; 501:141–149.
17.
ShafiqueM, AlviIA, AbbasZ, et al.Assessment of biofilm removal capacity of a broad host range bacteriophage JHP against Pseudomonas aeruginosa. Apmis, 2017; 125(6):579–584.
18.
SharmaS, DattaS, ChatterjeeS, et al.Isolation and characterization of a lytic bacteriophage against Pseudomonas aeruginosa. Sci Rep, 2021; 11(1):19393.
19.
OverbeekR, OlsonR, PuschGD, et al.The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res, 2014; 42(Database issue):D206–D214.
20.
CoudertE, GehantS, De CastroE, et al.; UniProt Consortium. Annotation of biologically relevant ligands in UniProtKB using ChEBI. Bioinformatics, 2023; 39(1):btac793.
21.
CamachoC, CoulourisG, AvagyanV, et al.BLAST+: Architecture and applications. BMC Bioinformatics, 2009; 10:421–429.
22.
HallgrenJ, TsirigosKD, PedersenMD, et al.DeepTMHMM predicts alpha and beta transmembrane proteins using deep neural networks. Biorxiv, 2022; 2022(04):08–487609.
23.
NavilleM, Ghuillot-GaudeffroyA, MarchaisA, et al.ARNold: A web tool for the prediction of Rho-independent transcription terminators. RNA Biol, 2011; 8(1):11–13.
24.
LoweTM, ChanPP. tRNAscan-SE On-line: Integrating search and context for analysis of transfer RNA genes. Nucleic Acids Res, 2016; 44(W1):W54–W57.
25.
AtheyJ, AlexakiA, OsipovaE, et al.A new and updated resource for codon usage tables. BMC Bioinformatics, 2017; 18(1):391–310.
26.
CouvinD, BernheimA, Toffano-NiocheC, et al.CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins. Nucleic Acids Res, 2018; 46(W1):W246–W251.
27.
MagillDJ, SkvortsovTA. DePolymerase Predictor (DePP): A machine learning tool for the targeted identification of phage depolymerases. BMC Bioinformatics, 2023; 24(1):208.
28.
TyneckiP, GuzińskiA, KazimierczakJ, et al.PhageAI-bacteriophage life cycle recognition with machine learning and natural language processing. BioRxiv, 2020; 2020(07).
29.
ShangJ, PengC, LiaoH, et al.PhaBOX: a web server for identifying and characterizing phage contigs in metagenomic data. Bioinform Adv, 2023; 3(1):vbad101.
30.
DicksLM, VermeulenW. Bacteriophage–Host Interactions and the Therapeutic Potential of Bacteriophages. Viruses, 2024; 16(3):478.
31.
Divya GaneshanS, HosseinidoustZ. Phage therapy with a focus on the human microbiota. Antibiotics (Basel), 2019; 8(3):131.
32.
AsifM, AlviIA, WaqasM, et al.A K-17 serotype specific Klebsiella phage JKP2 with biofilm reduction potential. Virus Res, 2023; 329:199107.
33.
AghaeeBL, Khan MirzaeiM, AlikhaniMY, et al.Improving the inhibitory effect of phages against Pseudomonas aeruginosa isolated from a burn patient using a combination of phages and antibiotics. Viruses, 2021; 13(2):334.
34.
Jończyk-MatysiakE, ŁodejN, KulaD, et al.Factors determining phage stability/activity: Challenges in practical phage application. Expert Rev Anti Infect Ther, 2019; 17(8):583–606.
35.
JeonG, AhnJ. Evaluation of phage adsorption to Salmonella Typhimurium exposed to different levels of pH and antibiotic. Microb Pathog, 2021; 150:104726.
36.
ShanJ, KorbsrisateS, WithatanungP, et al.Temperature dependent bacteriophages of a tropical bacterial pathogen. Front Microbiol, 2014; 5:599.
37.
AlviIA, AsifM, TabassumR, et al.Storage of bacteriophages at 4 C leads to no loss in their titer after one year. Pjz, 2018; 50(6).
38.
DelbrückM. The growth of bacteriophage and lysis of the host. J Gen Physiol, 1940; 23(5):643–660.
39.
KarthikaC, MalligarjunanN, Hari PrasathN, et al.Phage (cocktail)-antibiotic synergism: a new frontier in addressing Klebsiella pneumoniae resistance. Front Microbiol, 2025; 16:1588472.
40.
AkremiI, MerabishviliM, JlidiM, et al.Isolation and characterization of lytic Pseudomonas aeruginosa bacteriophages isolated from sewage samples from Tunisia. Viruses, 2022; 14(11):2339.
41.
AbedonST, HerschlerTD, StoparD. Bacteriophage latent-period evolution as a response to resource availability. Appl Environ Microbiol, 2001; 67(9):4233–4241.
42.
TajuddinS, KhanAM, ChongLC, et al.Genomic analysis and biological characterization of a novel Schitoviridae phage infecting Vibrio alginolyticus. Appl Microbiol Biotechnol, 2023; 107(2–3):749–768.
43.
AlviIA, AsifM, Ur RehmanS. A single dose of a virulent bacteriophage vB PaeP-SaPL, rescues bacteremic mice infected with multi drug resistant Pseudomonas aeruginosa. Virus Res, 2021; 292:198250.
44.
FoggP, RigdenD, SaundersJ, et al.Characterization of the relationship between integrase, excisionase and antirepressor activities associated with a superinfecting Shiga toxin encoding bacteriophage. Nucleic Acids Res, 2011; 39(6):2116–2129.
45.
ImamM, AlrashidB, PatelF, et al.vB_PaeM_MIJ3, a novel jumbo phage infecting Pseudomonas aeruginosa, possesses unusual genomic features. Front Microbiol, 2019; 10:2772.
46.
RajaureM. The Role of Spanins in Phage Lysis. 2015.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
